Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Performance and Complaints
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(664)
•••
Comment by DeathXray33on Nov 14, 2024 1:48pm
111 Views
Post# 36313196

RE:RE:RE:Performance and Complaints

RE:RE:RE:Performance and Complaints
DeathXray33 wrote:
rollthedice10 wrote: I agree. I think TLT knows what they have and they ain't giving it away.
The road is long but the rewards could be staggering.
I suspect I and many other shareholders will be staggering too!
Rome wasn't built in a day.


MRK is paying > $3.2 billion for La-Veggie anti-nobody. -------------------------------------------------------------"Merck is paying more than 10 times as much for a molecule that has only just begun human testing."


I'll put that one in the Slickconian value-bin. You definitely don't want your treatment from the value-bin; that's where you get two pairs of gloves for ten bucks. ------------------------------------------------------------- "there is a significant delay in tumour progression in mice treated with x-ray activated Rutherrin versus with radiation alone (p> 0.001). In fact, in mice treated with x-ray activated Rutherrin, the tumour is notably regressing / being destroyed over time."
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities